Liver disease is the eighth leading cause of death in the United States and the third or fourth leading cause of death among patients 45 to 64. To improve these outcomes, many hepatologists on the medical staffs of Baylor University Medical Center at Dallas and Baylor Scott & White All Saints Medical Center – Fort Worth are undertaking a number of notable patient-centered research projects. All research projects are administered by Baylor Scott & White Research Institute.
Baylor Scott & White All Saints Medical Center – Fort Worth is currently enrolling patients for a study designed to assess the impact of the Multi Point Pacing (MPP) feature at 12 months in the treatment of patients not responding to standard Cardiac Resynchronization Therapy (CRT) after 6 months.
The opioid epidemic has caused the incidence of acute hepatitis C (HCV) in the United States to triple over the last several years. More than 5 million people in the nation carry the virus. Because many of these people are undiagnosed, especially in high-risk populations, many organs from HCV-positive donors are still being procured.
